Therefore, it is attractiveto develop therapeutics targeting FZD7 for cancer treatment.Structure-based virtual screening has identified compound 28, whichinhibited WNT/β-catenin signaling based on the luciferase-basedreporter gene TOPFlash assay. This evidence concerns the gene FZD7 and cancer.